The potential of advanced peptide technologies in treating irreversible damage of tissues has boosted market growth. Additionally, peptide bioscience material is being applied to effective woundcare treatments for patients suffering from diabetes, obesity, and other disorders associated with lifestyle changes.
Biomatriq is a patented synthetic, biocompatible and bioresorbable material developed and patented by scientists from Stanford University. Biomatriq is a stable scaffold ideal as a medium for stem cell research and for a number of medical applications such as hemostasis and tissue regeneration.
Biomatriq enables cells to be cultured in tightly controlled microenvironments. The constructs resulting from our materials enhance important cell assays that are critical in predicting correct drug interactions and metabolism. Biomatriq improves cell types, assays in multiple cell types form complex structures including networks, synapses, vascularization and spheroids. This improves models for in vivo and in vitro research and testing with greater accuracy, predictability resulting in lower costs for drug development.
Biomatriq is well suited to most cell culture needs. As a 3-dimensional extracellular matrix, it simulates in-vivo growth environments for in vitro investigations. Our research shows the material is ideal for cell culture for the following uses among others:
- Hepatocyte toxicity, induction and metabolism assays
- Stem cell proliferation and differentiation assays
- Tumor cell migration and invasion
- Angiogenesis assays
- Cardiomyocyte cell culture and in vivo delivery
- Neurite outgrowth assays
- Co-culture of various cell types
- Osteoblast bone growth
- Chondrocyte and cartilage culture
- Endothelial, neural, osteoblast 3-D cell structure formation
- Tissue models for in vitro drug screening
- Tissue engineering research
- Bioproduction using XirTAM3® microcarriers in suspension culture
- In vivo analyses of tissue regeneration